• 中国核心期刊数据库收录期刊
  • 中文科技期刊数据库收录期刊
  • 中国期刊全文数据库收录期刊
  • 中国学术期刊综合评价数据库统计源期刊等

快速检索引用检索图表检索高级检索

中国医药导刊 ›› 2025, Vol. 27 ›› Issue (11): 1197-1197-1202.doi: magtech.2024.12.17-00002

• 中医中药 • 上一篇    下一篇

五味饮加减佐治急性血栓性浅静脉炎的疗效观察

廖宇1, 孙冉冉1, 郭宇清1, 王晓鹏1, 肖阳春1, 高美丽2*   

  1. 1.北京中医医院顺义医院,北京 101300;

    2.中国中医科学院望京医院,北京 100102

  • 收稿日期:2024-12-17 修回日期:2025-09-16 接受日期:2025-12-24 出版日期:2025-11-28 发布日期:2025-12-24
  • 基金资助:

    中国中医科学院科技创新工程课题(CI2021A02903)

Efficacy of Modified Wuwei Decoction in the Adjuvant Treatment of Acute Superficial Vein Thrombophlebitis

LIAO Yu1, SUN Ranran1, GUO Yuqing1, WANG Xiaopeng1, XIAO Yangchun1, Gao Meili2*   

  1. 1.Shunyi Hospital of Beijing Hospital of Traditional Chinese Medicine Beijing 101300, China
    2.China Academy of Chinese Medical Sciences Wangjing Hospital Beijing 100102, China
  • Received:2024-12-17 Revised:2025-09-16 Accepted:2025-12-24 Online:2025-11-28 Published:2025-12-24

摘要:

目的:观察五味饮加减佐治血热瘀结型急性血栓性浅静脉炎(SVT)的疗效。方法:选取20221月至20244月我院收治的152例急性SVT患者,按照随机数字表法分为西药组(予以常规治疗,n=76)和中西联合组(在西药组基础上联合五味饮加减治疗,n=76)。比较两组患者临床疗效,治疗前后中医症状积分、静脉临床严重程度评分(VCSS)、血液流变学指标(红细胞压积、纤维蛋白原、血浆黏度100 s、全血黏度200 s)、血清炎症因子水平[高敏-C反应蛋白(hs-CRP)、白细胞介素-6IL-6)、肿瘤坏死因子-αTNF-α)]及不良反应。结果:中西联合组治疗总有效率(97.37%)高于西药组(88.16%P<0.05)。治疗后,两组中医症状积分评分、VCSS评分、红细胞压积、纤维蛋白原、血浆黏度100s、全血黏度200shs-CRPIL-6TNF-α水平较治疗前均下降(P<0.05),且治疗后,中西联合组患者上述指标水平降低幅度均大于西药组(P<0.05)。两组患者不良反应发生率差异无统计学意义(P>0.05)。结论:五味饮加减佐治血热瘀结型SVT患者,可有效缓解其临床症状,血液流变学指标,降低炎症因子水平,对控制SVT病情进展具有一定疗效。

 

关键词: 急性血栓性或浅静脉炎, 五味饮, 血热瘀结型, 炎症因子, 血液流变学

Abstract:

Objective: To observe the efficacy of modified wuwei decoction adjuvant therapy on blood heat stasis accumulation type of acute superficial vein thrombophlebitis SVT.Methods: 152 patients with acute SVT admitted in our hospital from January 2022 to April 2024 were selected. According to the random number table method these patients were divided into the western medicine group routine treatmentn=76 and the combined Chinese-western medicine group modified wuwei decoction on the basis of the western medicine groupn=76. The clinical efficacy TCM symptoms scores venous clinical severity score VCSS), hemorheological indicators hematocrit fibrinogen plasma viscosity 100s whole blood viscosity 200s and serum inflammatory factors levels high-sensitivity C-reactive protein hs-CRP), interleukin-6 IL-6), tumor necrosis factor-α TNF-α)] before and after the treatment and the adverse reactions were compared between the two groups.Results: The total effective rate of treatment in the combined Chinese-western medicine group 97.37% was higher than that in the western medicine group 88.16%) (P<0.05. After treatment the scores of TCM symptoms the scores of VCSS the levels of hematocrit fibrinogen plasma viscosity 100 s whole blood viscosity 200 s hs-CRP IL-6 and TNF-α in both groups decreased compared with those before treatment P<0.05), and the decrease of the above indicators in the combined Chinese-western medicine group was greater than that in the western medicine group P<0.05. There were no statistically significant differences in the incidence rates of adverse reactions between the two groups of patients P>0.05.Conclusion: Modified wuwei decoction can effectively relieve the clinical symptoms and hemorheological indicators and reduce the levels of inflammatory factors in patients with SVT of blood heat stasis accumulation type and it has certain efficacy on controlling the progression of SVT.

[Key Words]  

Key words: Acute superficial vein thrombophlebitis , Wuwei decoction , Blood heat stasis accumulation type , Inflammatory factors , Hemorheology

中图分类号: